JPS59231085A - Alkaloid - Google Patents

Alkaloid

Info

Publication number
JPS59231085A
JPS59231085A JP58106506A JP10650683A JPS59231085A JP S59231085 A JPS59231085 A JP S59231085A JP 58106506 A JP58106506 A JP 58106506A JP 10650683 A JP10650683 A JP 10650683A JP S59231085 A JPS59231085 A JP S59231085A
Authority
JP
Japan
Prior art keywords
compound
formula
serotonin
methanol
propenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58106506A
Other languages
Japanese (ja)
Inventor
Eiji Nakamura
英士 中村
Reiko Abe
玲子 阿部
Junichi Kobayashi
淳一 小林
Yasushi Oizumi
康 大泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP58106506A priority Critical patent/JPS59231085A/en
Publication of JPS59231085A publication Critical patent/JPS59231085A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:The compound of formula (R is H or acyl). EXAMPLE:2-Amino-5-[3-(4-bromopyrrole-2-carboxamido)-1-propenyl]-1-meth ylimidazole. USE:It selectively suppresses the constricting activity of serotonin, and is expected e.g. as a hypotensor. PREPARATION:The compound of formula is obtained by crushing the sponge (Agelas species) of Kerama Islands, Okinawa Prefecture, Japan, extracting with a solvent such as methanol, and purifying by column chromatography.

Description

【発明の詳細な説明】 本発明はアルカロイドにHする。[Detailed description of the invention] In the present invention, H is added to an alkaloid.

本発明者等は種々の海産動物体内に含まれる生理活性物
質を探索中のところ、ある禅の海綿に含まれる新物質が
、平滑筋例えば血管のセロトニンによる収縮作用を選択
的に抑制する作用(抗セロトニン作用)を有することを
確認し。
The present inventors are searching for physiologically active substances contained in the bodies of various marine animals, and found that a new substance contained in a certain Zen sponge has the effect of selectively suppressing the contraction effect of serotonin on smooth muscles, such as blood vessels. Confirmed that it has anti-serotonin effect).

この知見に基づいて本発明を達成した。The present invention was achieved based on this knowledge.

即ち、本発明の要旨は。That is, the gist of the present invention is as follows.

式 (式中でRば、水素原子又はアシル基を示j)で表わさ
れるアルカロイドに存する。
It exists in an alkaloid represented by the formula (in the formula, R represents a hydrogen atom or an acyl group).

本発明の詳細な説明すると、上記式[/]で示される本
発明の化合物のうちでRが水素原子である化合物、即ち
、コーアミノ−s−[3−(グープロモビロールーコー
カルボキサミド)−/−フロベニル]−/−メfルイミ
タソール(以下化合物lという)は、ある種の海綿(A
gelai 5pecies )  を破砕し、後記実
施例に示すように、適当な溶媒で抽出し一カラムクロマ
トグラフィーによって精製することによって単離するこ
とができる。
To explain the present invention in detail, among the compounds of the present invention represented by the above formula [/], R is a hydrogen atom, that is, co-amino-s-[3-(gupromobilol-cocarboxamide)-/ -Flobenil]-/-mef limitasol (hereinafter referred to as compound l) is a substance that is found in certain sponges (A
gelai 5pecies), extracted with an appropriate solvent, and purified by one-column chromatography as shown in the Examples below.

また、前足〔73式におけるRがアシル基(アセチル基
、グロピオニル基、ブチリル基等)、例えばアセチル基
である化合物、即ち、コーアセチルアミノー5−(3−
(4t−ブロモピロール−2−力ルポキザミド)−/−
プロペニル〕−/−メチルイミダゾール(以下化合物コ
という)は、6fJ記化合・吻lを適当な溶媒中でアセ
チル化することによって得ることができる。
In addition, forepaw [compounds in which R in formula 73 is an acyl group (acetyl group, glopionyl group, butyryl group, etc.), for example, an acetyl group, that is, coacetylamino-5-(3-
(4t-bromopyrrole-2-lupoxamide)-/-
Propenyl]-/-methylimidazole (hereinafter referred to as compound 1) can be obtained by acetylating compound 6fJ in an appropriate solvent.

上記化合物/及びコは、文献未載の新規化合物であって
、?ヲ記実施例に示す、マススペクトル、UV吸収スペ
クトル、IR吸収スペクトル、’H−NMR及びIJC
−NMR等の測定結果から、それぞれの構造が確認され
た。
The above compound/and is a new compound that has not been published in any literature. Mass spectra, UV absorption spectra, IR absorption spectra, 'H-NMR and IJC shown in Examples
-The respective structures were confirmed from the results of measurements such as NMR.

本発明の化合物は、俊記参考例に示すように、抗セロト
ニン作用を示す。セロトニンは、哺乳動物の血清及び血
小板その他脳などに存在する物質であり、血゛aその他
平滑筋を収縮させる。
The compound of the present invention exhibits anti-serotonin action as shown in Reference Example Shunki. Serotonin is a substance present in the serum, platelets, and other brains of mammals, and causes blood aa and other smooth muscles to contract.

不発ゆjの化合物をよ、このセロトニンによる収縮作用
を選択的に抑制する作用を有し、例えば血圧降下剤とし
ての用途が期待される。
It has the effect of selectively suppressing the contraction effect caused by serotonin, and is expected to be used as a hypotensive agent, for example.

以下実施例により本発明を更に詳細に説明するが、本発
明は以下の実施例により限定されるものではない。
The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited to the Examples below.

実施例/ コーアミノーs−[、y−(ダーフロモピロール−、l
 −力/l/ ホキサアミド)−/−プロペニル〕−/
−メチルイミダゾール(化合物/)の単離沖縄按良問列
島産の海綿Agelas sp、  31# (湿重量
)を破砕してホモジナイズし、メタノール6tを用い室
温で3回抽出し、抽出液を減圧上濃縮乾固してgt、F
!−の粗抽出物を得た。この粗抽出物を7007のメタ
ノールに溶解し、不溶物を戸別し、P液を1liiL、
て7gfの油状物を得た。
Example/ Co-amino s-[, y-(derphlomopyrrole-, l
−force/l/ foxaamide)−/−propenyl]−/
- Isolation of methylimidazole (compound/) The sponge Agelas sp, 31# (wet weight) from Okinawa's Arayatoi Islands was crushed and homogenized, extracted three times at room temperature using 6 tons of methanol, and the extract was extracted under reduced pressure. Concentrate to dryness gt, F
! A crude extract of - was obtained. Dissolve this crude extract in 7007 methanol, remove insoluble matter, and add 1liiL of P solution.
7 gf of oil was obtained.

上記の油状物を2等分し、それぞれ別個のシリカゲルの
カラム(シリカゲル/qを充填した、直径ム2Cm、高
さgs(1)のカラム)に吸着させ、クロロホルム−メ
タノール(qs:5)tt。
The above oil was divided into two equal parts, each of which was adsorbed on a separate silica gel column (a column filled with silica gel/q, diameter 2 cm, height gs (1)), and chloroform-methanol (qs: 5) tt. .

クロロホルム−メタノール(?:/)りt、クロロホル
ム−メタ/−ル(g:a)tt、クロロホルム−メタノ
ール(/二/)乙を及びメタノール6tを用いてHA次
溶出し1,11りd/ll−の画分に分別した。双方の
第10−12査目の画分な合して濃縮し、得られた褐色
の油状物171−ケ、シリカゲルのフラッシュカラムク
口々トゲラフイー〔カラム:シリカゲル!;20’1−
1Sx s g cm ; %出液:クロロホルムーn
−ブタノール−酢酸−水(25:/、<7:/6:10
))にかけ、20θOm6〜.2700−の溶出画分を
集めて濃縮し、ユ6tの油状物を得た。この油状9勿欠
、h’J出液としてインアミルアルコール−酢酸−水<
3o :i3:io)を用いる以外は上記と同一のシリ
カゲルのフラッシュカラムクロマトグラフィーにかけ、
/ 2 /、 Od−/ 3g0−の溶出画分を集めて
譲縮し11oonqの油状物を得た@ 上記のようにして得た油状物ヲ、セファデックスLl(
−20(ファルマシア社製品)のカラムクロマトグラフ
ィー(カラム: 2.9 X g l、 cm、溶出1
佼:メタノール)にかけ、2go−〜39θ−の溶出画
分を集めて−細し、得られたlダ5〃lの油状物を、更
に上記セファデックスLH−20のカラムクロマトグラ
フィー〔カラム:ユ6×s3cwr、溶出液:クロロホ
ルムーメタノール(/ : / )EKかけ、 / ’
I O+nl〜2 /θ−の溶出画分欠集め、濃縮して
/ 、2 A mf/の黄褐色油状物を得た。この油状
wJヲ、逆相系高速液体クロマトグラフィー〔カラム:
 Develosil −OD S Oタノール(6:
+);流速:3雇/分;検出器:紫外庫27θ旨〕にか
け、床」)・時間/ふ6分のピークを集め、濃樹礼固し
で、粉末状のコーアミノ−!;−[3−(11,−ブ日
モピロールーλ−力ルポキザアミド)−/−プロペニル
]−i−メチルイミダゾール(化合物l)のトリフルオ
ロ酢酸塩グ、? l1lpを得た。氷晶の融点ば/g3
〜/g7c’i示し、FD−マススペクトルは、m /
 z 、7.24’、3.2乙にM +Hのイオ/ビー
りを与え、この結果から分子式C(p 1114 N5
08にであることが判明した。その構造は、下記UV吸
収スペクトル、IR吸収スペクトル、’H−NMR及び
”C−NMRのデータから、上記化合物/と決定されl
こ。
HA secondary elution using chloroform-methanol (?:/) t, chloroform-methanol (g:a), chloroform-methanol (/2/) and 6 t of methanol. It was fractionated into 11- fractions. Both fractions from the 10th to 12th scans were combined and concentrated, resulting in a brown oil (171-kg), which was poured into a flash column of silica gel.[Column: Silica gel! ;20'1-
1Sx s g cm; % solution: chloroform-n
-butanol-acetic acid-water (25:/, <7:/6:10
)) and 20θOm6~. The eluted fractions of 2,700- were collected and concentrated to obtain 6-t of oil. This oily 9 is essential, and the h'J exudate is inamyl alcohol - acetic acid - water <
Flash column chromatography on silica gel as above but using 3o:i3:io);
/2/, Od-/3g0- elution fractions were collected and concentrated to obtain 11oonq of oil.
-20 (Pharmacia product) column chromatography (column: 2.9 X g l, cm, elution 1
The eluate fractions from 2go- to 39θ- were collected and diluted, and 5 liters of the obtained oil was further subjected to the Sephadex LH-20 column chromatography [column: unit]. 6 x s3cwr, eluent: chloroform-methanol (/:/) EK applied, /'
The eluted fractions from IO+nl to 2/θ- were collected and concentrated to give a yellowish brown oil with IO+nl to 2 A mf/. This oily wJwo is subjected to reverse phase high performance liquid chromatography [column:
Develosil-ODSOtanol (6:
Flow rate: 3 hours/min; Detector: ultraviolet chamber 27θ], collect the peak at 6 minutes; ;-[3-(11,-mopyrrole-λ-poxamide)-/-propenyl]-i-methylimidazole (compound l) trifluoroacetate, ? l1lp was obtained. Melting point of ice crystals/g3
~/g7c'i, and the FD-mass spectrum is m/g7c'i.
z, 7.24', and 3.2B, give the ion/beam of M +H, and from this result, the molecular formula C (p 1114 N5
It turned out to be in 2008. Its structure was determined as the above compound from the following UV absorption spectrum, IR absorption spectrum, 'H-NMR and 'C-NMR data.
child.

U  V  (CH301−I)   λmax  :
  272  nm  (ε iqgoo)I l’L
 (KBr)  )/max: 33’lθ、 、32
70 、 # 90 、 /4.?θ。
UV (CH301-I) λmax:
272 nm (ε iqgoo) I l'L
(KBr) )/max: 33'lθ, , 32
70, #90, /4. ? θ.

/36!、/323,1200,1/紡、l/110 
t−nr−’’II−NMR(DMSO−d、、  δ
 in  pprr3)   +  3..3g(3H
,S)。
/36! , /323,1200,1/spinning, l/110
t-nr-''II-NMR (DMSO-d, δ
in pprr3) + 3. .. 3g (3H
,S).

’AO/ (,2H,t 、J = k、AHz)、!
r、g弘(/H,ABX2  center  。
'AO/ (,2H,t, J = k, AHz),!
r, g hiro (/H, ABX2 center.

dt、J=//、!;、AH2)、l−2θ(/H、d
 、A B center 、J=/ /H1)。
dt, J=//,! ;, AH2), l-2θ(/H, d
, A B center , J=/ /H1).

t、go(/H,dd、J−=2り、/jHz)、(−
9,2(/H,dd、J=ユタ。
t, go (/H, dd, J-=2ri, /jHz), (-
9,2 (/H, dd, J=Utah.

1jHz)、702(/H,S)、2!r9(2H,b
rsJ水〆添加で消失)、g;22(/H,brt、J
=!LAHz、j4水添加で消失//、3g (/H,
、bra 、 ’M水添加で消失) /191(/f(
、bro、市水添加で消失) 1sC−NMR(DMSO−d、  、δ in  p
pm)   :  2q、−Xq)  +J&A(tL
q左久s)、///7(d)、//、24d)、//J
8g(d)、/、2/、7(d)。
1jHz), 702(/H,S), 2! r9(2H,b
rsJ disappeared by adding water), g; 22 (/H, brt, J
=! LAHz, j4 Disappears by adding water//, 3g (/H,
, bra , 'M disappears by adding water) /191(/f(
, bro, disappeared by addition of city water) 1sC-NMR (DMSO-d, , δ in p
pm) : 2q, -Xq) +J&A(tL
qSakus), ///7(d), //, 24d), //J
8g(d), /, 2/, 7(d).

/、2J、7(a)、  /、2/、7(s)、  /
、?、?、、?(d)、  /ダ&9(s) 、  1
55!4(s)実施例コ コーアセチルアミノ−5−(,7−(y−プロモピロー
ルーユーカルボキザアミド)−t−プロペニル−7−メ
チルイミダゾール(化合物、2)実施91 /で得た化
合物7  <3. s my)をピリジン0、 / d
に溶解し、無水酢酸0.0コ〃iを加え室温でコ時間反
応させた。反応混合物な減圧下蒸発乾固し、その残渣を
クロロホルム−メタノール(ざ夕:15)を展開溶媒と
して用いたシリカゲル薄層クロマトグラフィーによりA
’N 製して、無色結晶のコーアセテルアミノ−6−−
[’ 、? −(グーブロモビロール−λ−カルボキサ
アミド)−/ −フロベニル] −/ −7’−7−ル
イミタソール(化会物コ)θA myを得た。本市の融
点は2AO〜264’C(分解)であり、EI−マスス
ペクトル、U V吸収スペクトル、I R吸収スペクト
ル及び’H−NMRの測定値は次の110すであった。
/, 2J, 7(a), /, 2/, 7(s), /
,? ,? ,,? (d), /da&9(s), 1
55!4(s) Example Cocoacetylamino-5-(,7-(y-promopyrrole-eucarboxamide)-t-propenyl-7-methylimidazole (Compound, 2) Compound obtained in Example 91/ 7 <3.s my) with pyridine 0, / d
0.0 μl of acetic anhydride was added to the mixture, and the mixture was reacted at room temperature for several hours. The reaction mixture was evaporated to dryness under reduced pressure, and the residue was purified by silica gel thin layer chromatography using chloroform-methanol (15%) as a developing solvent.
'N Coacetelamino-6-- produced as colorless crystals
[',? -(gubromovirol-λ-carboxamide)-/-flobenil]-/-7'-7-limitasol (chemical compound) θA my was obtained. The melting point of Motoichi was 2AO to 264'C (decomposition), and the measured values of EI-mass spectrum, UV absorption spectrum, IR absorption spectrum, and 'H-NMR were as follows.

EI−へ’is:、3A7,3乙jt、、3j3’2.
3!i0.3ツタ、32λ。
EI-to'is:, 3A7, 3 otsu jt,, 3j3'2.
3! i0.3 ivy, 32λ.

/93 UV(CH30H)λmax:ηi ’I nrn (
ε、2/11.0θ)IR(KBr)  1/Irna
x:、3.170,2930./Ag!r 、/l、、
3θ。
/93 UV(CH30H)λmax:ηi 'I nrn (
ε, 2/11.0θ) IR (KBr) 1/Irna
x:, 3.170,2930. /Ag! r, /l,,
3θ.

tsss 、 tg;to cm−’ ’H−、NMm(DMso−d6.δin ppm) 
:、2.0’1(3H,S) +3.34’(JH,S
)、’AOk(!H,m)、Jニア0(dt 。
tsss, tg; to cm-''H-, NMm (DMso-d6.δin ppm)
:, 2.0'1(3H,S) +3.34'(JH,S
),'AOk(!H,m),Jnear0(dt.

J=//、ム/I(z)、4.70(d、J=//Hz
)。
J=//, Mu/I(z), 4.70(d, J=//Hz
).

/、Ii/(dd、J=14L、3.θHz)、&デ3
(dtl、J=llI。
/, Ii/(dd, J=14L, 3.θHz), &de3
(dtl, J=llI.

、?01(z)、ム?、7(S) 、g、/7 (br
s)、//j?(brs)参考例 雄性ウサギ(!j〜3 kti )をは〈殺し、放血後
、胸部大動脈を摘出し、1隔1IIII711のら線状
に切った後、長さp II+の切片を作製した。これを
クレブス−リンゲル液を入れた容量λθtnlのマグヌ
ス管中に1@垂し、液温を、?7Cに保持してか゛ 9J%02−左% co2混合混合シス気した。この大
動脈切片にlψの静止張力を付加し、薬物投与AfJ 
/時間インギュベーションした。ついで、これに実施例
/で得た化合物/ (/!jX#)−’M)を投与し、
30分後に、セロトニン(/×lθ−6M)。
,? 01(z), Mu? ,7(S) ,g,/7(br
s), //j? (brs) Reference Example A male rabbit (!j~3 kti) was sacrificed, and after exsanguination, the thoracic aorta was removed, cut in a rectangular shape at 1 septum 1III711, and sections with length p II+ were prepared. This was poured into a Magnus tube with a capacity of λθtnl containing Krebs-Ringer's solution, and the temperature of the solution was set to ? The temperature was maintained at 7C and a 9J% 02-left% CO2 mixture was introduced. A resting tension of lψ was applied to this aortic section, and drug administration AfJ
/ hours of incubation. Then, the compound obtained in Example/(/!jX#)-'M) was administered to this,
After 30 minutes, serotonin (/×lθ-6M).

ノルエピネフリ:/(/X/(1;l−7M)  及び
KCICtpxlo−2M)  を夫々別個疋投与して
、その等張性収縞の変化をトランジューサーを介して記
録計に記録した。
Norepinephrine: / (/

その結果、化合物/の投与によ・、って、セロトニンに
よる切片の収縮反応は完全に抑制されたが、ノルヱピネ
フリン及びKCIによる切片の収縮反応は殆んど抑制さ
れなかった。即ち、化合物/は、セロトニンによるウサ
ギ大動脈の収帽反応を選択的に抑制する、抗セロトニン
作用を示す。
As a result, by administering the compound, the contraction response of the slices caused by serotonin was completely suppressed, but the contraction response of the slices caused by norepinephrine and KCI was hardly suppressed. That is, compound / exhibits an anti-serotonin effect that selectively inhibits the serotonin-induced captivity reaction in the rabbit aorta.

出願人  三菱化成工業株式会社 代理人  弁理士 長谷用  − ほか/名 第1頁の続き 0発 明 者 大泉康 町田市南犬谷字11号916番地の 2株式会社三菱化成生命科学研 究所内Applicant: Mitsubishi Chemical Industries, Ltd. Agent: Patent Attorney Hase - Others/names Continuation of page 1 0 shots: Yasushi Oizumi 916, Minamiinuya Aza 11, Machida City 2 Mitsubishi Kasei Life Science Institute Co., Ltd. Inside the laboratory

Claims (1)

【特許請求の範囲】[Claims] (1)  下記式 (式中でRは、水素原子又はアシル基を示す。)で表わ
されるアルカロイド。
(1) An alkaloid represented by the following formula (in the formula, R represents a hydrogen atom or an acyl group).
JP58106506A 1983-06-14 1983-06-14 Alkaloid Pending JPS59231085A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58106506A JPS59231085A (en) 1983-06-14 1983-06-14 Alkaloid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58106506A JPS59231085A (en) 1983-06-14 1983-06-14 Alkaloid

Publications (1)

Publication Number Publication Date
JPS59231085A true JPS59231085A (en) 1984-12-25

Family

ID=14435309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58106506A Pending JPS59231085A (en) 1983-06-14 1983-06-14 Alkaloid

Country Status (1)

Country Link
JP (1) JPS59231085A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152071A1 (en) * 2008-06-09 2009-12-17 Vanderbilt University Unnatural dispyrin analogues, preparation and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152071A1 (en) * 2008-06-09 2009-12-17 Vanderbilt University Unnatural dispyrin analogues, preparation and uses thereof

Similar Documents

Publication Publication Date Title
IE881324L (en) Osides
JPH09511530A (en) Synthetic insulin mimetics
JPS58219177A (en) Medicine containing (+)-cyanidan-3-ol derivative, substituted (+)-cyanidan-3-ol derivative and manufacture
Norup et al. The potencies of thapsigargin and analogues as activators of rat peritoneal mast cells
JPS59231085A (en) Alkaloid
Wolfrom et al. The identification of aldose sugars by their mercaptal acetates
EP0251039B1 (en) Esters of salsalate with guaiacol, for treating phlogistic bronchopneumopathies
Slama et al. The synthesis of glycolipids containing a hydrophilic spacer-group
Rappoport et al. Preparation of L-Arabinose-1-C14 1
JP2986592B2 (en) Method for separating 24-position epimer of 24-hydroxycholesterol derivative
Petrušová et al. A nitro sugar derivative route to 2-thioepisophorose and 2-thiosophorose and their remarkable facile epimerization
JPS6157594A (en) Galactosphingolipid and its production
US4895853A (en) Antitumor alkaloids
JPH085866B2 (en) Novel aconitine compounds and analgesic / anti-inflammatory agents
EP0073834B1 (en) Water-soluble cholesterol derivatives
Baer et al. I. MESYL ESTERS OF GLYCEROL
JPH01224396A (en) Novel steroid saponin and production and novel use of these derivative
JP3006902B2 (en) Monoterpene glycoside
JPS62240679A (en) Pyrrole compound
ES2718417B2 (en) Procedure for converting 24R epimers of vitamin D precursors into the corresponding 24S isomer and procedure for obtaining calcipotriol.
EP0117260B1 (en) 4-aminobutyric acid derivatives, a process for the preparation thereof and a pharmaceutical composition containing said derivatives
JPH01186836A (en) Terpene compound
JPS59128348A (en) Monoterpenylbenzoquinone and its preparation
JPS63203694A (en) Farnesol glycoside
JPH0592990A (en) Cardenolide derivative